Compound Detail
CHEMBL308801
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC1(C)Oc2ccc3cc(C(Br)Br)c(=O)oc3c2[C@@H](OC(=O)C23CCC(C)(C(=O)O2)C3(C)C)[C@H]1OC(=O)C12CCC(C)(C(=O)O1)C2(C)C
Basic Information
| ChEMBL ID | CHEMBL308801 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XVPZWHVQUMJAAP-UUECEZJRSA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
794.5
MW (Da)
6.49
ALogP
11
HBA
0
HBD
144.6
PSA (Ų)
0.14
QED
3
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 9.92
IC50 1 meas. best 5.5
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| H9 | EC50 | = | 0.119 | nM | 9.92 | Inhibitory concentration against HIV-1 replication in acutely infected H9 lympho... | 11527717 |
| H9 | IC50 | = | 3200.0 | nM | 5.5 | Inhibitory concentration required to inhibit uninfected H9 cell growth by 50% | 11527717 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11527717 | 10.1016/s0960-894x(01)00437-1 | H9 | 2 |
| 11527717 | 10.1016/s0960-894x(01)00437-1 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine